Presentations At Conventions
- Presentation at the 5th ACTC | Advances in Circulating Tumor Cells | Liquid Biopsy: Latest Advances and Future, 22-25 Sept 2021, Kalamata, Greece.
JUNB and CXCR4 expression in Circulating Tumor Cells (CTCs) isolated from Non-Small (NSCLC) and Small Cell (SCLC) Lung Cancer Patients patients.
5th ACTC | Advances in Circulating Tumor Cells | Liquid Biopsy: Latest Advances and Future, 22-25 2021, Sept, Kalamata, Greece
E. Pantazaka, A. Ntzifa, S. Tsakas, E. Lianidou, A. Kotsakis, V. Georgoulias and G. Kallergi Evaluation of PD-L1/pS6 on circulating tumor cells in patients with non-small-cell lung cancer treated with Osimertinib.
5th ACTC | Advances in Circulating Tumor Cells | Liquid Biopsy: Latest Advances and Future, 22-25, 2021 Sept, Kalamata, Greece.
E. Pantazaka, D. Graikioti, C.M. Athanassopoulos and G Kallergi Evaluation of the anti-tumor effect of artesunate on adherent and non-adherent (CTCs’ model) non-small-cell lung and breast cancer cell lines.
- Presentation at the 2nd International meeting on Lung Cancer. Athens 22-23 Oct. Athens 2021.
Identification of PD-L1 and ps6 expression in circulating tumor cells of osimertinib-treated non-small-cell lung cancer patients.
Δημοσιεύσεις Σε Συνέδρια
- Evangelia Pantazaka, Vasileios Vardas, Argyro Roumeliotou, Stavros Kakavogiannis , Galatea Kallergi. Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients, Cancers (Basel) 2021 Apr 29;13(9):2158.
- Vasileios Vardas, Eleni Politaki, Evangelia Pantazaka, Vassilis Georgoulias and Galatea Kallergi. Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis. Int. J of Dev Biology (under press)